ACTH	adrenocorticotropic hormone
AUC	area under the curve
BMI	body mass index
BMD	bone mineral density
CT	computed tomography
CI	confidence interval
CLIA	Clinical Laboratory Improvement Amendments
DST	dexamethasone suppression test
DHEA-S	dehydroepiandrosterone-sulphate
DXA	Dual-Energy X-Ray Absorptiometry
ECLIA	electrochemiluminescence immunoassay
FRAX	Fracture Risk Assessment Tool
GLP-1	glucagon-like peptide-1 agonist
HF	10-year hip fracture risk
LTD	largest tumour diameter
MOF	10-year major osteoporotic fracture risk
MACS	mild autonomous cortisol secretion
M	median
N	number of patients
NFAT	non-functioning adrenal tumour
PTH	parathyroid hormone
P1NP	procollagen type 1 N-terminal pro-peptide
ROC	receiver operating characteristic
RANKL	receptor activator of nuclear factor κβ ligand
Q	quartile
SD	standard deviation
SOp	secondary osteoporosis
TBS	trabecular bone score
WHO	World Health Organization